EUROFINS SCIENT PE Ratio 2018-2024 | ERFSF
Current and historical p/e ratio for EUROFINS SCIENT (ERFSF) from 2018 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. EUROFINS SCIENT PE ratio as of July 10, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| EUROFINS SCIENT PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-10 | 71.25 | 0.00 | |
| 2024-12-31 | 51.85 | 0 | 0.00 |
| 2024-06-30 | 47.82 | 0 | 0.00 |
| 2023-06-30 | 62.50 | 0 | 0.00 |
| 2022-12-31 | 69.59 | 0 | 0.00 |
| 2021-12-31 | 120.52 | 0 | 0.00 |
| 2021-06-30 | 110.51 | 0 | 0.00 |
| 2020-12-31 | 77.65 | 0 | 0.00 |
| 2020-06-30 | 60.13 | 0 | 0.00 |
| 2019-12-31 | 53.35 | 0 | 0.00 |
| 2019-06-30 | 40.98 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.751B | $7.522B |
| Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.077B | 27.58 |
| CVS Health (CVS) | United States | $83.011B | 10.32 |
| Elevance Health (ELV) | United States | $78.142B | 10.08 |
| Cencora (COR) | United States | $57.628B | 20.05 |
| DiDi Global (DIDIY) | China | $23.768B | 25.25 |
| Natera (NTRA) | United States | $22.306B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.229B | 17.22 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| Solventum (SOLV) | United States | $13.128B | 13.90 |
| CochLear (CHEOY) | Australia | $12.788B | 0.00 |
| ICON (ICLR) | Ireland | $12.281B | 11.42 |
| Revvity (RVTY) | United States | $12.070B | 20.77 |
| Viatris (VTRS) | United States | $10.857B | 3.73 |
| Medpace Holdings (MEDP) | United States | $9.434B | 25.06 |
| Avantor (AVTR) | United States | $9.336B | 13.56 |
| Sonic Healthcare (SKHHY) | Australia | $8.582B | 0.00 |
| HealthEquity (HQY) | United States | $8.405B | 36.81 |
| Charles River Laboratories (CRL) | United States | $8.038B | 15.75 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.772B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.024B | 29.58 |
| BrightSpring Health Services (BTSG) | United States | $3.667B | 33.65 |
| Sotera Health (SHC) | United States | $3.375B | 19.18 |
| Surgery Partners (SGRY) | United States | $2.855B | 37.12 |
| Alignment Healthcare (ALHC) | United States | $2.647B | 0.00 |
| Concentras Parent (CON) | United States | $2.621B | 15.15 |
| Organon (OGN) | United States | $2.605B | 2.77 |
| GeneDx Holdings (WGS) | United States | $2.480B | 95.51 |
| Ardent Health (ARDT) | United States | $2.041B | 8.70 |
| Progyny (PGNY) | United States | $2.024B | 44.55 |
| PACS (PACS) | United States | $1.949B | 0.00 |
| Premier (PINC) | United States | $1.767B | 13.41 |
| GoodRx Holdings (GDRX) | United States | $1.750B | 35.00 |
| Teladoc Health (TDOC) | United States | $1.546B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.329B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.160B | 8.82 |
| CareDx (CDNA) | United States | $1.149B | 17.94 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.956B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.846B | 7.92 |
| QDM (QDMI) | Hong Kong, SAR China | $0.846B | 290.00 |
| Nutex Health (NUTX) | United States | $0.653B | 9.89 |
| Embecta (EMBC) | United States | $0.627B | 4.22 |
| InnovAge Holding (INNV) | United States | $0.567B | 0.00 |
| SBC Medicals (SBC) | United States | $0.552B | 0.00 |
| LifeMD (LFMD) | United States | $0.544B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.486B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.471B | 10.60 |
| Omada Health (OMDA) | $0.461B | 0.00 | |
| So-Young (SY) | China | $0.389B | 0.00 |
| Enhabit (EHAB) | United States | $0.375B | 30.88 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.348B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.338B | 0.00 |
| Beauty Health (SKIN) | United States | $0.257B | 0.00 |
| Oncology Institute (TOI) | United States | $0.256B | 0.00 |
| DocGo (DCGO) | United States | $0.153B | 25.00 |
| Pheton Holdings (PTHL) | China | $0.134B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.104B | 0.00 |
| KindlyMD (NAKA) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.079B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.055B | 0.00 |
| ModivCare (MODV) | United States | $0.054B | 0.00 |
| Biodesix (BDSX) | United States | $0.045B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.023B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |